Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
HIV drug research in Wales to cut infection risk

Nearly 400 people have been taking part in a three-year trial of the drugs in Wales since last summer. Cardiff University will now examine how people have been taking the medicine - and if that affects the protection.

Published
16 August 2018
From
BBC
Privilege and Profit Corrupt the PrEP Access Debate

If most folks are getting their PrEP for free, then who cares what Gilead charges? Peter Staley explains why ALL of us should care.

Published
15 August 2018
From
Poz
People taking HIV-prevention pill may get more primary care

When people take daily pills to minimize their chances of getting HIV, they are also more likely to get routine care like flu shots and recommended screenings for common health problems, a U.S. study suggests.

Published
15 August 2018
From
Reuters
Declining HIV numbers bolstered by new prevention drug but more data needed

Changes to HIV medications are on the horizon just a few months after New Zealand became one of the first countries to publicly fund a "revolutionary" prevention drug. National regulator Pharmac has begun a three-week tender process for a selection of antiretroviral treatments (ARTs) to be provided to hospitals and community pharmacies around the country.

Published
13 August 2018
From
Stuff.nz
PrEP use taking off in Thailand and Vietnam

Pre-exposure prophylaxis (PrEP) use is accelerating among men who have sex with men and transgender women in two south-east Asian countries where it is receiving

Published
13 August 2018
By
Gus Cairns
Why Do Some Gay and Bi Men Stigmatize PrEP Users?

A focus-group-based study parsed men’s attitudes about pre-exposure prophylaxis.

Published
10 August 2018
From
Poz
PrEP scales up, HIV incidence declines

As use of PrEP continues to grow, epidemiological evidence is starting to show a link between increased use and declines in new HIV infections.

Published
09 August 2018
From
BETA blog
New Zealand: Pharmac widens access to 'revolutionary' HIV-prevention drug

Hundreds of prescriptions for a "revolutionary" HIV-prevention drug have been approved in the first few months of it being more widely available. Pharmac expanded access to Truvada in March. In the first three months, 695 people got the medication for the first time, paying $5 for a three-month prescription.

Published
08 August 2018
From
Newshub
Gilead Said PrEP To Prevent HIV Was 'Not A Commercial Opportunity.' Now It's Running Ads For It

The commercial, aptly titled "I'm on the Pill," is part of a marketing push that has helped turned the use of Truvada for preventing HIV into a $1.3 billion blockbuster, almost 5% of Gilead's annual sales.

Published
07 August 2018
From
Forbes Magazine
PrEP spreads across Africa – slowly

This year, 2018, will be the year that a really significant number of people in Africa started HIV pre-exposure prophylaxis (PrEP), the 22nd International AIDS Conference

Published
06 August 2018
By
Gus Cairns
← First12345...145Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.